Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 31 December 2024
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
61
Euro (EUR)
14
Renminbi (CNY)
10
Indian rupee (INR)
7
Swiss franc (CHF)
3
Other currencies (CAD, DKK, GBP, HDK, SEK)
5
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
31
Public (from private) companies
26
Public companies
23
Funds
10
Cash and cash equivalents
8
Other assets
2
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
40
Products on the market
22
Phase I
5
Phase II
23
Phase III
7
Preclinical
3
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
27
Oncology
17
Central nervous system
13
Synthetic biology
11
Immunology/Inflammation
11
Digital Health
8
Orphan diseases
8
Medical technology / diagnostics
5
#87b164
#cb2648
#8c74af
#00a4c8
#dc6c3f
#e5ae1f
#49753d
#21659a
#cab415
#423e3d